NEW YORK (GenomeWeb News) — Synthetic genetics company Codon Devices has pocketed $20 million in a Series B round of venture capital financing, Codon said today.
Codon CEO John Danner said the company will use the cash to develop its BioFAB production platform, which uses informatics, robotics, and sequencing technology to synthesize gene codes.
In July Codon reported it had built a 35-kilobase gene cluster for the pharmaceutical company Microbia.
The company also plans use the money to expand its protein and metabolic engineering and will push ahead with a global sales agenda.
Highland Capital Partners led the round. Contributors included Alloy Ventures, Flagship Ventures, Khosla Ventures and Kleiner Perkins Caufield & Byers.